JP2010510286A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510286A5
JP2010510286A5 JP2009537627A JP2009537627A JP2010510286A5 JP 2010510286 A5 JP2010510286 A5 JP 2010510286A5 JP 2009537627 A JP2009537627 A JP 2009537627A JP 2009537627 A JP2009537627 A JP 2009537627A JP 2010510286 A5 JP2010510286 A5 JP 2010510286A5
Authority
JP
Japan
Prior art keywords
vinyl acetate
ethylene
drug
formulation
acetate copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009537627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/062626 external-priority patent/WO2008062008A1/en
Publication of JP2010510286A publication Critical patent/JP2010510286A/ja
Publication of JP2010510286A5 publication Critical patent/JP2010510286A5/ja
Withdrawn legal-status Critical Current

Links

JP2009537627A 2006-11-22 2007-11-21 非ステロイド非イオン化親水性薬物の送達系 Withdrawn JP2010510286A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062626 WO2008062008A1 (en) 2006-11-22 2007-11-21 Delivery system for a non-steroidal non-ionized hydrophilic drug

Publications (2)

Publication Number Publication Date
JP2010510286A JP2010510286A (ja) 2010-04-02
JP2010510286A5 true JP2010510286A5 (enExample) 2011-01-13

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009537628A Withdrawn JP2010510287A (ja) 2006-11-22 2007-11-21 リスペリドン用送達システム
JP2009537627A Withdrawn JP2010510286A (ja) 2006-11-22 2007-11-21 非ステロイド非イオン化親水性薬物の送達系

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009537628A Withdrawn JP2010510287A (ja) 2006-11-22 2007-11-21 リスペリドン用送達システム

Country Status (6)

Country Link
US (2) US20100104619A1 (enExample)
EP (2) EP2094348A1 (enExample)
JP (2) JP2010510287A (enExample)
CA (2) CA2670454A1 (enExample)
MX (2) MX2009005444A (enExample)
WO (2) WO2008062009A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
AU2007274081B2 (en) * 2006-07-12 2012-08-02 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
WO2008062009A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for risperidone
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
BRPI0919465A2 (pt) * 2008-09-30 2015-12-01 Endo Pharmaceuticals Solutions dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
CA2792484C (en) * 2009-03-12 2017-10-31 Delpor, Inc. Implantable device for long-term delivery of drugs
EP2547332B1 (en) 2010-03-16 2018-08-29 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
MX2020012459A (es) * 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
WO2002076426A2 (en) * 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
NZ537991A (en) * 2002-08-30 2007-08-31 Alza Corp Embossable and writable multilaminate backing construction
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
WO2005089723A1 (en) * 2004-03-24 2005-09-29 N.V. Organon Drug delivery system based on polyethylene vinylacetate copolymers
RS53890B1 (sr) * 2004-11-10 2015-08-31 Tolmar Therapeutics, Inc. Stabilizovan polimerni sistem za isporuku
WO2008062021A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
WO2008062009A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for risperidone

Similar Documents

Publication Publication Date Title
JP2010510286A5 (enExample)
US20240261278A1 (en) Abuse-resistant mucoadhesive devices for delivery of buprenorphine
RU2404750C2 (ru) Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту
JP2009525343A5 (enExample)
CA2628200A1 (en) Solid pharmaceutical compositions containing pregabalin
CA2661759A1 (en) Buprenophine-wafer for drug substitution therapy
FI3287124T3 (fi) Ketamiinin oraalinen annosmuoto
JP2011529854A5 (enExample)
US20210308040A1 (en) Ketamine oral transmucosal delivery system
RS51696B (sr) Transdermalni granisetron
CN103096881A (zh) 含有具有不愉快味道的药物的膜制剂
JP2012533565A5 (enExample)
Lee et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
JP2013541583A5 (enExample)
HRP20140592T1 (hr) Poboljšani medicinski pripravci koji sadrže buprenorfin i naltrekson
JP2011503044A5 (enExample)
JP2008543936A5 (enExample)
CN103610666A (zh) 一种盐酸普拉克索透皮贴剂及其制备方法
JP2010520184A5 (enExample)
JP2012505830A5 (enExample)
HRP20140591T1 (hr) Poboljšani medicinski pripravci koji sadrže buprenorfin i nalmefen
JP2018039810A5 (enExample)
JP2016505050A5 (enExample)
IL300144A (en) Benzazepines are combined for the treatment of Tourette syndrome